Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/US Executive Order fast-tracks psychedelic drug research, boosting Kala Bio and client Red Light Holland.
TRIP
$14.54
+$0.54 +3.86%

US Executive Order fast-tracks psychedelic drug research, boosting Kala Bio and client Red Light Holland.

Market News
21 Apr 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

US President Donald Trump signed an Executive Order accelerating psychedelic drug research by prioritizing FDA reviews, easing DEA restrictions, expanding patient access, and allocating $50 million in federal funding. This policy shift significantly benefits Kala Bio and its client Red Light Holland by enhancing regulatory and commercial momentum for their psychedelic drug programs. Kala Bio's AI platform, Researgency.ai, supports Red Light Holland's clinical development, positioning Kala as a key AI partner in the biotech and psychedelic sectors. The move marks a major step toward integrating psychedelic medicine into mainstream healthcare under a supportive federal framework.

More News (TRIP)

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

In Q2 2026, Longleaf Small-Cap Fund saw positive contributions from New York real estate firms Alexander’s and Empire State Realty Trust, as well as travel company Tripadvisor. However, Boston Beer negatively impacted the quarter due to mixed short-t...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App